Review




Structured Review

EPS Corporation web-based randomization system
The risk of bias of included trials (Authors judgment/Evidence for judgment).
Web Based Randomization System, supplied by EPS Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/web-based+randomisation+system+trust/web+based+randomization+system/pmc08283176-21-5-8
Average 90 stars, based on 1 article reviews
web-based randomization system - by Bioz Stars, 2026-10
90/100 stars

Images

1) Product Images from "Safe and Effective Treatment for Anemic Patients With Chronic Kidney Disease: An Updated Systematic Review and Meta-Analysis on Roxadustat"

Article Title: Safe and Effective Treatment for Anemic Patients With Chronic Kidney Disease: An Updated Systematic Review and Meta-Analysis on Roxadustat

Journal: Frontiers in Pharmacology

doi: 10.3389/fphar.2021.658079

The risk of bias of included trials (Authors judgment/Evidence for judgment).
Figure Legend Snippet: The risk of bias of included trials (Authors judgment/Evidence for judgment).

Techniques Used: Sequencing, Capsules

Related Articles

other:

Article Title: Phase 3, Randomized, Double-Blind, Active-Comparator (Darbepoetin Alfa) Study of Oral Roxadustat in CKD Patients with Anemia on Hemodialysis in Japan
Article Snippet: Assignment was implemented by a web-based randomization system (EPS Corporation, Tokyo, Japan), conducted with a dynamic allocation method using a biased-coin minimization approach.

Article Title: Phase 3, Randomized, Double-Blind, Active-Comparator (Darbepoetin Alfa) Study of Oral Roxadustat in CKD Patients with Anemia on Hemodialysis in Japan
Article Snippet: Study Drug Administration Assignment was implemented by a web-based randomization system (EPS Corporation, Tokyo, Japan), conducted with a dynamic allocation method using a biased-coin minimization approach.

Article Title: Historical changes and between-facility differences in adrenal venous sampling for primary aldosteronism in Japan.
Article Snippet: Primary aldosteronism (PA) is a common curable cause of hypertension.. Adrenal venous sampling (AVS) is recommended for subtype diagnosis but is a difficult procedure.. Recently, an increased prevalence of PA was reported, creating a greater demand for treatment of the condition in clinical facilities.

Article Title: Dual antiplatelet therapy using cilostazol for secondary prevention in patients with high-risk ischaemic stroke in Japan: a multicentre, open-label, randomised controlled trial
Article Snippet: Department of Cerebrovascular Medicine, National Cerebral and Cardiovascular Centre, Osaka, Japan (K Toyoda MD, T Yamaguchi MD); Clinical Research Centre for Medicine, International University of Health and Welfare, Tokyo, Japan (S Uchiyama MD); Centre for Brain and Cerebral Vessels, Sanno Hospital and Sanno Medical Centre, Tokyo, Japan (S Uchiyama); Department of Neurology, University of California, San Francisco, CA, USA (J D Easton MD); Department of Neurological Science, Graduate School of Medicine, Nippon Medical School, Tokyo, Japan (K Kimura MD); Department of Neurology, Tokyo Saiseikai Central Hospital, Tokyo, Japan (H Hoshino MD); Department of Neurosurgery, Kobe City Medical Centre General Hospital, Kobe, Japan (N Sakai MD); Clinical Research Institute and Department of Cerebrovascular Medicine and Neurology, National Hospital Organisation Kyushu Medical Centre, Fukuoka, Japan (Y Okada MD); Department of Neurology (K Tanaka MD) and Division of Biostatistics and Clinical Epidemiology (H Origasa PhD), University of Toyama, Toyama, Japan; Department of Neurology, Senri Chuo Hospital, Toyonaka, Japan (H Naritomi MD); Department of Neurosurgery, Hokkaido University Graduate School of Medicine, Sapporo, Japan (K Houkin MD); Department of Neurology, Ichinomiya Nishi Hospital, Ichinomiya, Japan (K Yamaguchi MD); Department of Neurosurgery, Kushiro Rosai Hospital, Kushiro, Japan (M Isobe MD); and Headquarters of the Iseikai Medical Corporation, Osaka, Japan (K Minematsu MD) Dual antiplatelet therapy using cilostazol for secondary prevention in patients with high-risk ischaemic stroke in Japan: a multicentre, open-label, randomised controlled trial

Article Title: Safe and Effective Treatment for Anemic Patients With Chronic Kidney Disease: An Updated Systematic Review and Meta-Analysis on Roxadustat
Article Snippet: (NCT02952092) , Low risk/By a web-based randomization system (EPS corporation, tokyo, Japan) , Low risk/Dynamic allocation was conducted using a biased-coin minimization approach , Low risk/Double blind study , Low risk/Double blind study , Low risk/All dropped-out patients have been reported , Low risk/Information for this study available from Clincialtrials.gov , outcomes reported as planned in Clinicaltrials.gov.

Article Title: Randomised phase II trial of mFOLFOX6 plus bevacizumab versus mFOLFOX6 plus cetuximab as first-line treatment for colorectal liver metastasis (ATOM trial)
Article Snippet: Randomisation was based on dynamic allocation by a minimisation method in a centralised web-based system (EPS Corporation, Tokyo, Japan).

Sequencing:

Article Title: Targeted therapy for advanced anaplastic lymphoma kinase (<i>ALK</i> )-rearranged non-small cell lung cancer
Article Snippet: .. Cochrane Database of Systematic Reviews Notes Risk of bias Bias Authors' judgement Support for judgement Random sequence generation (selection bias) Low risk Quote: "Patients were randomly assigned in a 1:1 ratio, using a stratified permuted-block method" Allocation concealment (selection bias) Low risk Quote: "an interactive web response system (IxRS; EPS Corporation, Tokyo, Japan) using a randomisation code generated independently by the IxRS vendor." ..

Selection:

Article Title: Targeted therapy for advanced anaplastic lymphoma kinase (<i>ALK</i> )-rearranged non-small cell lung cancer
Article Snippet: .. Cochrane Database of Systematic Reviews Notes Risk of bias Bias Authors' judgement Support for judgement Random sequence generation (selection bias) Low risk Quote: "Patients were randomly assigned in a 1:1 ratio, using a stratified permuted-block method" Allocation concealment (selection bias) Low risk Quote: "an interactive web response system (IxRS; EPS Corporation, Tokyo, Japan) using a randomisation code generated independently by the IxRS vendor." ..

Generated:

Article Title: Targeted therapy for advanced anaplastic lymphoma kinase (<i>ALK</i> )-rearranged non-small cell lung cancer
Article Snippet: .. Cochrane Database of Systematic Reviews Notes Risk of bias Bias Authors' judgement Support for judgement Random sequence generation (selection bias) Low risk Quote: "Patients were randomly assigned in a 1:1 ratio, using a stratified permuted-block method" Allocation concealment (selection bias) Low risk Quote: "an interactive web response system (IxRS; EPS Corporation, Tokyo, Japan) using a randomisation code generated independently by the IxRS vendor." ..



Similar Products

90
Tayside Pharmaceuticals web-based randomisation system trust
Web Based Randomisation System Trust, supplied by Tayside Pharmaceuticals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/web-based+randomisation+system+trust/web+based+randomisation+system/pmc11709295__pone__0306163__s002-193-17-23
Average 90 stars, based on 1 article reviews
web-based randomisation system trust - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
Tayside Pharmaceuticals web-based tayside randomisation system trust
Web Based Tayside Randomisation System Trust, supplied by Tayside Pharmaceuticals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/web-based+randomisation+system+trust/web+based+randomisation+system/pmc04449962-138-3-2
Average 90 stars, based on 1 article reviews
web-based tayside randomisation system trust - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

Image Search Results